Bain Capital Life Sciences III General Partner, LLC
CIK 0001952106
10% Owner
Filings
5
Latest Apr 30, 2026
Issuers covered
3
Showing
5 of 5
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 33% | -1.5% | -5.5% | +18.3% | -9.9% |
| 90 days | 2 | 0% | -28.8% | -28.8% | -6.5% | -51.1% |
| 180 days | 1 | 0% | -78.2% | -78.2% | -78.2% | -78.2% |
| 365 days | 1 | 0% | -90.2% | -90.2% | -90.2% | -90.2% |
Issuers
Companies where Bain Capital Life Sciences III General Partner, LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| HTFL | Heartflow, Inc. | 3 | Apr 30, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | 1 | Feb 14, 2024 |
| NAMS | Newamsterdam Pharma Co N.V. | 1 | Dec 17, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|